The new compounds synthesized by sequential reactions starting from a diamine 4-(4-aminophenyl)thiazol-2-amine 1 (which results from the reaction of 4-aminoacetophenon and thiourea with iodide), the compound 1 was reacted with chloroacetic acid to yield 2-(4-(4-(Carboxymethylamino)phenyl)thiazol-2-ylamino)acetic acid 2. While the 5-((4-(4-((5-amino-1,3,4-thiadiazol-2-yl)methylamino)phenyl)thiazol-2-ylamino)methyl)-1,3,4-thiadiazol-2-amine 3 was obtained from the reaction of compound 2 with thiosemicarbazide in POCl3. Finally reacted the compound 3 with different aromatic aldehydes or ketone to produce Schiff bases compounds 4a–4f. The synthesized derivatives characterized via FT-IR, 1H NMR and mass spectroscopy. The biological activity of the synthesized compounds was evaluated against two types of bacteria gram-positive (Staphylococcus aureus) and gram-negative (Escherichia coli) as well as against one type of fungus, the results show moderate activity against the bacteria under study.
Alheety et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: